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A Survey of Validation Strategies 
for CRISPR-Cas9 Editing
Monica F. Sentmanat2, Samuel T. Peters1, Colin P. Florian2, Jon P. Connelly1 & Shondra M. 
Pruett-Miller1
The T7 endonuclease 1 (T7E1) mismatch detection assay is a widely used method for evaluating the 
activity of site-specific nucleases, such as the clustered regularly interspaced short palindromic repeats 
(CRISPR)-Cas9 system. To determine the accuracy and sensitivity of this assay, we compared the editing 
estimates derived by the T7E1 assay with that of targeted next-generation sequencing (NGS) in pools 
of edited mammalian cells. Here, we report that estimates of nuclease activity determined by T7E1 
most often do not accurately reflect the activity observed in edited cells. Editing efficiencies of CRISPR-
Cas9 complexes with similar activity by T7E1 can prove dramatically different by NGS. Additionally, we 
compared editing efficiencies predicted by the Tracking of Indels by Decomposition (TIDE) assay and the 
Indel Detection by Amplicon Analysis (IDAA) assay to that observed by targeted NGS for both cellular 
pools and single-cell derived clones. We show that targeted NGS, TIDE, and IDAA assays predict similar 
editing efficiencies for pools of cells but that TIDE and IDAA can miscall alleles in edited clones.
Advances in genome engineering have ushered in exciting new opportunities for scientists to understand and 
enhance biology. Programmable nucleases enable targeted genomic modifications, which can aid in the study 
of biological mechanisms involved in disease development, drug discovery, personalized medicine, agriculture 
productivity, and even environmental sustainability1. Although several nuclease platforms have been developed, 
including zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), the recently 
engineered clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 system is widely used, 
despite its more recent implementation. The popularity of the CRISPR-Cas9 platform can be attributed to its 
conceptually straightforward design: a single cloning step generates a single guide RNA (sgRNA) that directs 
Cas9-mediated endonuclease activity to the site of interest. This circumvents the multistep cloning process 
required for the assembly of the protein-based DNA binding domains that direct ZFNs and TALENs. Moreover, 
unlike Cas9 nucleases, the FokI nuclease domain of ZFNs and TALENs functions as a dimer, requiring the design 
of two proteins with strict orientation and spacing constraints. In contrast, the only design constraint limiting the 
commonly used S. pyogenes Cas9 nuclease is the requirement of a 5′-NGG-3′ protospacer adjacent motif (PAM) 
on the target template immediately following the sgRNA target sequence. However, this prerequisite can be made 
more flexible by using Cas9 orthologs with different PAM sequence specificities2,3.
Cas9 binding is PAM-dependent, and upon complementary base pairing of the sgRNA to the DNA target, 
Cas9 produces a targeted double-strand break in the DNA4. This break is then repaired by the endogenous 
cellular repair machinery and can lead to local insertion and/or deletion events (indels) via the nonhomolo-
gous end-joining (NHEJ) pathway or to precise sequence modification via homology-directed repair when a 
user-defined donor template is provided.
Not all sgRNAs are equally efficacious at directing Cas9-mediated DNA modifications. This is, in part, because 
some sequence contexts do not permit optimal sgRNA design. Inclusion of preferential bases within the sgRNA 
sequence (e.g., a guanine at position 20, proximal to the PAM), at the variable position of the PAM site (preference 
for cytosine), or immediately following the PAM sequence (A/C/T) can positively influence sgRNA activity, but 
such bases may not be present at the desired target site5. Moreover, chromatin structure and particular sequence 
elements (e.g., high GC-content or low-complexity features) may preclude the targeting of some genomic 
sequences, affecting sgRNA activity5–7. Therefore, validation strategies for quantifying the modification frequen-
cies of CRISPR-Cas9 reagents are typically implemented to evaluate activity.
In this study, we explored the accuracy of four assays (T7E1, TIDE, IDAA and NGS) frequently used to deter-
mine the level of activity for a given sgRNA when complexed with Cas9. We compared the rates of editing at 19 
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loci in human and mouse genomes assayed by targeted NGS and T7E1. We find that because of a low dynamic 
range and a requirement for DNA heteroduplex formation, the T7E1 assay often incorrectly reports sgRNA activ-
ities. We also evaluated the reliability of TIDE and IDAA analysis and found that both methods are very predic-
tive of overall sgRNA activity. However, neither the TIDE nor the IDAA assay predicted both indel size and indel 
frequency for all edited clones tested. While TIDE accurately predicted all indel sizes from tested clones, TIDE 
deviated by more than 10% of the targeted NGS predicted indel frequencies in 50% of clones tested. IDAA accu-
rately predicted 25% of both indel sizes and frequencies for the tested clones. Overall, our work defines some of 
the major limitations and advantages of each of the most commonly used sgRNA validation assays.
Results
Targeted NGS improves selection of high activity sgRNAs. The T7 endonuclease 1 (T7E1) is a struc-
ture-selective enzyme that detects structural deformities in heteroduplexed DNA8. In using this assay to detect 
CRISPR-Cas9-mediated gene editing, reagents are transfected into cells, and the genomic DNA surrounding 
the target locus is amplified several days later by PCR. This PCR product is then denatured and recomplexed 
by heating and subsequent slow cooling. If an aberrant NHEJ event has occurred after CRISPR-Cas9 cleavage, 
a heteroduplex will form between amplicons of different lengths (e.g., mutant and WT amplicons), leading to a 
DNA distortion that is recognized and cleaved by T7E1. The banding patterns of the cut products are compared 
between control and experimental samples to determine the frequency of mutations.
The T7E1 assay is a cost-effective, technically simple, and easy to interpret method to validate CRISPR rea-
gents. Identified from Escherichia coli bacteriophage, T7E1 resolves branched phage DNA for packaging during 
capsid maturation, and has been shown to cut DNA at the 5′ base of cruciform DNA in vitro9–11. However, the 
performance of the assay may be impacted by the length and identity of base pair mismatches, flanking sequence, 
secondary structure, and relative abundance of mutant sequence8,12,13. To determine the accuracy and sensitivity 
of the T7E1 assay for indels produced by CRISPR-Cas9, we compared the NHEJ frequency estimates derived by 
the T7E1 assay and targeted next-generation sequencing (NGS). We tested 19 sgRNAs targeting human (H1–H9, 
Table 1) and mouse (M1–M10, Table 1) genes in K562 and N2a cells, respectively. We used nucleofection to 
transfect sgRNA and S. pyogenes Cas9 (SpCas9) expressing plasmid DNAs and harvested cell lysates 3 to 4 days 
post-nucleofection. We performed targeted PCR and prepared the resulting amplicons for mismatch detection by 
T7E1. Although the T7E1 assay is error prone due to subjective bias (e.g., manually choosing troughs to estimate 
peak area for densitometry) and high background (e.g., excessive banding), predictable banding patterns are 
apparent in cell pools edited by low- or high-performing sgRNAs. For example, features common to low-activity 
sgRNAs include parental (i.e., uncut) band intensities that are equal to the negative control and cut products that 
may be barely visible above background (M1 and M5, Fig. 1A). Alternatively, a feature common to moderate- and 
high-activity sgRNAs is a reduction in the parental band intensity relative to that of the negative control, concom-
itant with elevated band intensities in the cut products of expected sizes (M3 and H7, Fig. 1A).
We observed that the overall frequency of mutations detected by the T7E1 assay for all mouse and human 
sgRNAs averaged 22%, with 6 of 10 mouse sgRNAs and 5 of 9 human sgRNAs ranging between 17% and 29% 
(Table S1). The highest activity detected was 41% (Fig. 1B and Table S1). These findings are consistent with those 
in a previous report, in which a peak T7E1 signal of 37% was achieved with a 50% mix of WT and mutant alleles12. 
Target Sequence (5′ → 3′) GC (%) Location
H1a TCATATAGTCGCTTTTCTTNGG 35 Coding
H2 AATGGGGACGATTGGGCAAANGG 57 Coding
H3 CTCACCAGTACTCTGCTTTCNGG 50 Noncoding
H4 TGTCTGGGGACACGTCTCCANGG 57 Coding
H5 TCCTCAGCATCTTATCCGAGNGG 52 Coding
H6 GAATGAAAATGCGGTTCTTGNGG 48 Coding
H7 GTCATCTCTACCTGCGACCANGG 57 Coding
H8 GTCCCCTTCTGCCCAATGGTNGG 65 Coding
H9 CCGTCACTGAGACAGTGCGCNGG 65 Coding
M1b TATAGCCAGGCGAGTCCCCANGG 65 Coding
M2 GAGCATAGGCTATGACACAANGG 48 Noncoding
M3 GAGGAAGGACGCCCCCAGCANGG 70 Noncoding
M4 TGGAGACTGTGAAGGTGCTCNGG 57 Coding
M5 AGGACTTCCCCGACACCCAGNGG 35 Coding
M6 ACACTTTATTGTGCTTGTATNGG 35 Splice junction
M7 AACCTCCTCGAACGCGGGAGNGG 70 Coding
M8 TAGCCAAGTGCTACCGCGTANGG 57 Noncoding
M9 CCGGGAATACGACGTGGGCNGG 74 Coding
M10 GGCCTTGGCGTCCTGGTCTTNGG 70 Coding
Table 1. Summary of sgRNA Targets. aHuman targets are denoted by H1–H9. bMouse targets are denoted by 
M1–M10. Sequence, %GC content, and annotated feature (Human GRCh38/hg38 Gencode v24 for human and 
GRCm38/mm10 GENCODE M14 for mouse).
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We compared our T7E1 results with targeted NGS by creating a tailed library of the PCR amplicons used for the 
T7E1 assays for 2 × 250 bp sequencing on the MiSeq platform. The NGS data revealed a greater breadth of activ-
ity of the sgRNAs and a higher overall NHEJ frequency than did the T7E1 assay. With NGS, an average of 68% 
sgRNA activity for all mouse and human sgRNAs was detected, and 9 individual sgRNAs yielded indel frequen-
cies of 70% or greater (Fig. 1B and Table S1). Although it was expected that NGS would provide a higher dynamic 
range, we anticipated the overall trend in activity for all sgRNAs to be consistent between methods. NGS revealed 
three major sources of inaccuracy in the T7E1 assay. First, poorly performing sgRNAs with less than 10% NHEJ 
events detected by NGS appeared to be entirely inactive by T7E1 (H3, Fig. 1B). Second, highly active sgRNAs 
with greater than 90% NHEJ events detected by NGS appeared modestly active in the T7E1 assay (M1 and M5, 
Fig. 1B). Third, sgRNAs with apparently similar activity detected by the T7E1 assay were actually considerably 
different when detected by NGS. For example, the M2 and M6 sgRNAs both exhibited ~28% activity in the T7E1 
assay, but NGS demonstrated that the M6 pools had half the indel frequency of M2 pools (40% M6 vs 92% M2, 
Fig. 1B and Table S1). These data are consistent with those in previous reports, suggesting that the T7E1 assay is 
not reliable when indel frequencies exceed 30%14.
Targeted deep-sequencing can be used to determine indel frequencies generated by CRISPR-Cas915. However, 
this PCR-based method is subject to PCR bias for smaller amplicons, template switching, and can result in jack-
potting of alleles with large deletions. To determine if NGS of edited pools consisting of 1–15 bp indels accurately 
reflects true editing efficiency, we compared indel frequencies found in M4 and M10 cell pools to single cell 
derived clones generated from sequenced pools, 136 and 105 clones, respectively (Fig. 2A). The frequency of 
indels were comparable between cell pools and clones, as well as across indel sizes – ranging from 1 bp insertions 
to −15 bp deletions (Fig. 2B). Overall, this data suggests that this NGS approach for assessing editing efficiencies 
in cell pools can accurately portray individual editing events within pools.
A lack of indel diversity attenuates T7E1 detection of CRISPR-Cas9 mutations. The T7E1 assay is 
well suited for detecting indel variants resulting from aberrant NHEJ events, yet single nucleotide polymorphisms 
are poorly recognized8,12,16. To determine how the indel makeup of a pool of edited amplicons generated from 
cells treated with CRISPR-Cas9 reagents affects T7E1 assay outcomes, we mapped the indel distributions of four 
highly active sgRNAs with NGS-identified indel frequencies greater than 90%. Two of these sgRNAs exhibited 
low indel frequencies in the T7E1 assay (M1 and M5), and two exhibited moderate to high activity (M3 and H7) 
(Fig. 1A). The M1 and M5 sgRNAs displayed representation bias of a −1-bp deletion in more than 70% of reads 
(Fig. 1C). Both sgRNA sequences contained a dinucleotide homopolymer at the site of the double-strand DNA 
break (Fig. 1C). This sequence microhomology most likely contributed to the preferential repair outcomes during 
NHEJ17. Such bias in indel composition may be a limiting factor for heteroduplex formation, which is necessary 
for T7E1 mismatch recognition. Approximately half of the indel population from the M3 sgRNA was composed 
Figure 1. CRISRP-Cas9 activity reported with the T7E1 Assay and Next-Generation Sequencing. (A) NHEJ 
frequency with the T7E1 assay. Representative gel images of T7E1-treated PCR products amplified from the 
target sites of GFP-negative controls (−) and edited pools (+). (B) NHEJ events in CRISPR-Cas9 targets 
reported by NGS (black bars) or the T7E1 assay (grey bars). Data represent the mean of three biological 
replicates ±SEM. (C) Indel size spectrum (x-axis) and frequency (y-axis) identified by targeted NGS. The top 
four most prevalent reads are shown below the sgRNA sequence (5′ to 3′) with corresponding deletions (black 
dashes) and insertions (red letters). Red arrows identify sgRNA cut sites. Data represent the mean of three 
biological replicates ±SEM.
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of a single +1-bp indel. The highest frequency indel from the H7 sgRNA was present in only a quarter of the pool, 
which yielded a two-fold increase in the T7E1 signal for the H7 sgRNA (Fig. 1B). Although the NGS findings 
indicated that the M3 and H7 sgRNAs cut equally well (>90% efficiency, Fig. 1C), the T7E1 assay estimated that 
the H7 sgRNA contained two-fold greater activity than did the M3 sgRNA. Interestingly, the indel size distribu-
tion was also wider for the H7 sgRNA, in which a −7-bp deletion accounted for 15% of reads and 3-bp and 2-bp 
deletions each accounted for 10% of reads. Indel size heterogeneity was greater for the moderately active M3 
sgRNA (>20% reads consisted of a 1- to 5-bp deletion, Fig. 1C) than for the poorest performing pools (M1 and 
M5). These data suggest that pools with a diverse indel population after CRISPR-Cas9 editing more closely reflect 
the overall editing efficiency as reported by the T7E1 with an upper level of detection at approximately 30–40%.
The T7E1 signal is more associated with indel distribution than with overall sgRNA activity, in which the 
T7E1 signal was stronger for less indel-biased samples. When indel frequencies are plotted for each sample in 
ascending %NHEJ order based on NGS data (as in Fig. 1A) two trends emerge that explain the discrepancies 
between the T7E1 and NGS data (Fig. 3A). First, high activity sgRNAs with a single dominant indel lack sufficient 
amplicon diversity for an accurate T7E1 assay (e.g. M1 and M5). Second, targets with T7E1 signals above 20% 
have more widespread distributions across 2 or more indel species (e.g. M4 and H7).
Homoduplexing of high frequency indels most likely attenuates T7E1 sensitivity because the relative availa-
bility of WT (or alternate indel) species for heteroduplex formation is scarce. Given that some sgRNAs generated 
a high proportion (>50%) of single indel species, low T7E1 signals may be a consequence of the lack of heterog-
enous template in the pooled population.
To test if the limiting determinant for T7E1 sensitivity is the presence of a heterogeneous template, we used a 
one-to-one ratio of amplicons generated from untargeted and targeted N2a cell pools for heteroduplex formation. 
We assayed heteroduplexes by T7E1 predicting that pools harboring high NHEJ frequencies (>90% by NGS) 
with low indel complexities (i.e., M1,a single −1-bp deletion in >70% of amplicons) would most greatly improve. 
In addition, the abundance of WT amplicons provided by the WT amplicons spike-in would allow for a more 
accurate quantitative estimate of relative activity across sgRNAs – generating data more congruent with targeted 
deep-sequencing. Indeed, the one-to-one ratio of WT-to-targeted template resulted in improved detection across 
all samples tested (Fig. 3B). The M1 pool improved by T7E1 from 10 to 46%, which is the expected T7E1 signal 
plateau12. Pools M2 and M6 also showed T7E1 signals that better reflected their overall NHEJ rates, with M2 at 
35% (previously 27%, 92% by NGS) and M6 at 31% (previously 29%, 39% by NGS). Thus, spiking-in WT ampli-
con prior to heterocomplexing PCR products can increase the accuracy of the T7E1 assay. One caveat of this 
approach is that low frequency editing may fall below the limit of detection.
Figure 2. Targeted deep-sequencing of edited pools and single cell derived clones. (A) Overall indel frequency 
measured by targeted deep sequencing for M10 and M4 edited cell pools (blue) and clones (red). (B) 
Comparison of indel sizes and frequencies between M4 and M10 cell pools (blue) and individual clones (red). 
Indel frequencies for M4 and M10 clones were averaged across 136 and 105 individual clones, respectively.
Figure 3. Improved T7E1 sensitivity with amplicon diversity. (A) Histogram of the top 4 indels and WT 
sequence across all targets ordered from lowest to highest in activity reported by targeted deep sequencing. A 
line diagram of T7E1 frequency data for each target is shown below the histogram for reference (also shown 
in Fig. 1B). Data represents average of three biological replicates. (B) T7E1 assay for M1, M2, and M6 pools 
heterocomplexed with a 1:1 mixture of amplicons generated from targeted and untargeted wild type (WT) 
pools. The %NHEJ represents average of two biological replicates.
www.nature.com/scientificreports/
5Scientific RePoRTS |  (2018) 8:888  | DOI:10.1038/s41598-018-19441-8
TIDE and IDAA detect indels with similar frequency to targeted NGS in cell pools. Targeted NGS 
of edited pools can improve gene-editing efficiency by revealing which sgRNA design yields the greatest activ-
ity and desired indel frequency (i.e., out-of-frame indels for gene knockout). Although advances in sequencing 
technology have greatly reduced cost, NGS remains cost prohibitive for small sample sizes. Recently, the Tracking 
of Indels by Decomposition (TIDE) algorithm was created to analyze Sanger sequence traces generated from 
convoluted samples18. This method resolves indel size frequencies from edited cell populations by comparing 
and decomposing Sanger traces made from PCR products of targeted regions from WT and edited templates. We 
compared NHEJ event estimates and indel frequencies of TIDE-coupled Sanger sequencing and targeted NGS for 
three sgRNA pools: M9, M10, and H4. All major indels (>5%) identified by NGS were also identified by TIDE 
at comparable frequencies (Fig. 4A). Although TIDE tended to overestimate the presence of WT amplicon by 
~10–20% (Fig. 4A and Supplemental Fig. 1), it was useful in discerning the spectrum and relative frequency of 
distinct indels after CRISPR-Cas9 editing from pools of edited clones.
A similar and cost-efficient, site-specific nuclease validation assay is the Indel Detection by Amplicon Analysis 
(IDAA) assay19. The IDAA assay uses tri-primer amplicon labeling followed by DNA capillary electrophoresis. In 
brief, gene-specific primers are used in conjunction with a third FAM-6 labeled primer to amplify and label PCR 
amplicons obtained from edited genomic DNA. The labeled amplicons are then subjected to capillary electropho-
resis, which allows peaks to be called based on size and fluorescence intensity. By comparing labeled amplicons 
from WT cells to those of edited cells, one can determine the frequency and size of indels present in a population. 
We compared NHEJ event estimates and indel frequencies of IDAA to that of NGS and TIDE for sgRNA pools 
M9, M10, and H4. All major indels (>5%) identified by NGS and TIDE were also identified by IDAA at compara-
ble frequencies (Fig. 4A). Similar to TIDE, IDAA tends to overestimate the presence of WT amplicon by ~10–20% 
(Fig. 4A and Supplemental Fig. 1), but was useful in discerning the spectrum and relative frequency of distinct 
indels after CRISPR-Cas9 editing from pools of edited clones. One limitation that we observed with the IDAA 
assay is that we had to manually call the peaks −1-bp and +1-bp from the WT peak as the peak calling software 
(Peak Scanner 2) was not able to call these peaks. This was due to the peaks being in very close proximity to the 
WT peak (with fluorescent intensities more than double of any other peak). Moreover, most of the tri-primer 
amplicons obtained in our experiments (including WT controls) contained a −1 bp “shoulder” indel that is sug-
gested to be due to incomplete 3′ adenine nucleotide addition to the IDAA amplicon20 (Supplemental Fig. 2). This 
results in a higher −1-bp frequency for IDAA amplicons compared to NGS or TIDE (Fig. 4A).
To further compare the sensitivities and dynamic ranges of NGS, TIDE, IDAA, and T7E1 assays, we per-
formed a spike-in experiment in which we added increasing amounts of CRISPR-edited genomic DNA to WT 
genomic DNA (Supplemental Fig. 1). Overall, in both loci tested, NGS yielded the highest indel frequencies and 
the highest R2 coeffecient (0.9999 and 0.9916). TIDE and IDAA indel frequencies were similar and about 10–20% 
lower than targeted NGS. The fit of the trend line was less for IDAA largely due to higher than predicted values 
at samples containing lower amounts of edited genomic DNA. The higher values at the lower indel containing 
samples were a direct result of the −1 bp “shoulder” observed in other IDAA samples from the incomplete ade-
nine addition (Supplemental Fig. 2). For example, the fit is better for loci 1, which had a minor −1 bp shoulder 
compared with loci 2. Moreover, a 60 minute final extension time and a proof-reading polymerase were used in 
efforts to reduce the problematic −1 bp shoulder, but with little improvement20. IDAA results may improve with 
Figure 4. CRISPR-Cas9 activity reported by TIDE-Coupled Sanger Sequencing, Next-Generation Sequencing, 
and IDAA. (A) Indel spectrum and frequency predicted by TIDE, NGS, and IDAA from three pools of edited 
cells. (B) Comparison of NGS, TIDE, and IDAA for eight edited clones. The most prevalent reads (>5%) by 
targeted NGS are shown below the sgRNA sequence (5′ to 3′) with corresponding deletions (black dashes) and 
insertions (red letters). Red arrows identify sgRNA cut sites. The allele frequencies determined by NGS, TIDE, 
and IDAA are depicted in the adjacent table. Allele frequency and indel identity miscalls by TIDE or IDAA are 
highlighted in red or blue, respectively. Alignments labelled with an asterisk (*) represent indels with insertions 
and/or deletions that span beyond the sgRNA area represented.
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further primer optimization or by using a polymerase without adenine tailing. T7E1 trend lines fit well with an 
R2 coefficient of over 0.96 for both loci. However, T7E1 indel frequencies were similar to the other assays at low 
amounts of edited genomic DNA, but were significantly less as the amount of edited DNA increased. It should be 
noted that the indel diversity for both tested loci was high, which likely increased the fit of the trend line for the 
T7E1 samples (Supplemental Fig. 1B).
TIDE and IDAA can miscall alleles in edited clones. Identifying edited clones derived from 
CRISPR-Cas9 treated pools commonly involves TA cloning of PCR products amplified from the edited region, 
transforming the resultant plasmids into bacterial cells, and picking individual colonies for Sanger sequencing. 
This process is laborious, time consuming, and not necessarily accurate because cells maintained in culture, par-
ticularly cancer cell lines, are often karyotypically abnormal, resulting in unknown copy numbers21,22. Therefore, 
many colonies must be sequenced to obtain full allelic representation. We tested the precision of TIDE-coupled 
Sanger sequencing and IDAA compared to targeted NGS for the genotyping of a panel of 8 clones produced 
from various mouse and human cell lines (Fig. 4B). The clones contained distinct indel ratios identified by NGS. 
Clones with indels containing only a deletion or an insertion per allele were classified as “simple” while clones 
with concomitant insertions and deletions were classified as “complex”. For simple deletion clones C1, C2, and C5 
allelic fractions from NGS suggested the presence of 4 alleles (e.g. C1 2:1:1, C2 3:1, C5 2:1:1). The indel identities 
and fractions were correctly called by TIDE for all three simple clones, while IDAA miscalled indels for C1 and 
C2 (Fig. 4B, highlighted in blue). Both TIDE and IDAA miscalled indel sizes or frequencies for all complex clones 
except clone C8 (Fig. 4B, miscalled indel sizes highlighted in blue, miscalled frequencies highlighted in red). 
Overall, TIDE was able to correctly call all indel sizes for both simple and complex indels, but TIDE miscalled the 
indel frequency in 50% of the clones. IDAA correctly called both the indel size and frequency in 25% of clones. 
The presence of inaccurate frequencies and unexpected indels can confound clone verification and suggest con-
tamination with other clonal populations arising from the same edited pool. Additionally, although both TIDE 
and IDAA analysis did correctly predict that all 8 edited clones were knockout clones (lacked WT alleles), neither 
assay specifies the sequence identity of called indels and, consequently, does not eliminate the need for laborious 
TA cloning and Sanger sequencing procedures to obtain the accurate genotype of a given clone.
Discussion
These results suggest that the NHEJ frequency estimated by the T7E1 mismatch detection assay is often incon-
sistent with the actual frequency of editing in pools of cells. The findings of the T7E1 assay were more congruent 
with those of NGS in heteroduplexed pools containing a lack of indel bias. We found the T7E1 assay had a low and 
limited detection range that plateaued at 30 to 40% for CRISPR-Cas9 edited pools, which was below the average 
activity of sgRNAs assayed (63% for all mouse and human guides) and resulted in unreliable NHEJ frequencies 
across target regions. Dilution of PCR products from targeted regions with WT amplicons increased the accuracy 
of the T7E1 signal suggesting that high activity sgRNAs that produce a single, dominant indel (e.g. due to local 
microhomology) may show a low T7E1 signal. Therefore, caution should be applied when using T7E1-based 
quantitative indel estimates, as comparing various CRISPR-Cas9 design or protocol conditions with the T7E1 
assay may lead to inaccurate conclusions. Our results suggest that edited cell pools consisting of high-complexity 
indels with a diverse range of sizes exert a stronger influence on T7E1 sensitivity than does overall editing effi-
ciency (Fig. 3A).
We also show that indel estimates with TIDE and IDAA are typically congruent with those of targeted NGS, 
although likely at underestimated frequencies in assayed pools of amplicons. This suggests that TIDE or IDAA 
can aid in sgRNA selection when particular indels are desired (e.g., out-of-frame or gene-disrupting indels) 
or when comparing activities of multiple gRNAs. TIDE and IDAA assays was less reliable when performed on 
individual clones especially those containing complex indels. Additionally, TIDE relies on high quality Sanger 
sequencing traces, which cannot be easily obtained for every genomic locus. Additionally, TIDE most accurately 
predicts indels of limited size. For example, the default range for the TIDE algorithm is −10 bp to +10 bp. Going 
beyond this window reduces the confidence level18. TIDE is also limited in sensitivity and can only identify indels 
up to about 1–2%. With the currently available analysis programs, IDAA requires one to manually look at peaks 
from a control sample and the edited sample and likely manually call peaks that may overlap in order to get accu-
rate indel representation. Additionally, most of the tri-primer amplicons that we tested yielded a −1 bp shoulder 
that confounded interpretation of results. Moreover, neither TIDE nor IDAA reports the sequence identity of 
identified indels, and therefore, does not abrogate the need for additional sequencing in order to determine the 
genotype of a clone.
In comparing targeted NGS to other activity assays such as the T7E1, TIDE, or IDAA assays, it is important 
to note that the cost and labor involved in setting up an NGS pipeline, including sequence analysis, may be pro-
hibitive for labs working with few samples and/or sgRNA targets. Although NGS can have high error rates at 
GC- and AT-rich regions and homopolymer stretches, the overall error rate tends to be low at <0.4%23. Indeed, 
every new NGS platform strives for higher precision at longer read lengths that will one day allow high through-
put means to assess larger structural editing events not easily performed with the current technology. It is also 
important to note that all of the aforementioned assays give useful results in many cases. For example, we have 
not observed false positive results with the T7E1, TIDE, or IDAA assays. Thus, if a sgRNA is shown to be active 
by any of these assays, one can have high confidence that there is cutting occurring. All four assays (NGS, T7E1, 
TIDE and IDAA) are PCR-based assays and therefore have some additional limitations. For example, none of the 
approaches can detect large mutations such as translocations or large deletions that remove one or both primer 
binding sites. Additionally, PCR-based assays can show bias for smaller amplicons, and a limited number of 
amplification cycles should be used when possible.
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In conclusion, although the T7E1 assay is commonly used to report genome editing frequencies, we show 
that this assay often does not accurately portray true sgRNA activities. The TIDE and IDAA assays more closely 
resemble targeted NGS predicted indel sizes and frequencies for pools of cells and are easily performed by most 
molecular biology labs. However, both TIDE and IDAA can miscall indel frequencies and/or indel sizes from 
single-cell derived clones. Additionally, neither assay specifies the sequence identity of identified indels and, con-
sequently, does not eliminate the need for laborious TA cloning and Sanger sequencing procedures to obtain 
the accurate genotype of a given clone. Moreover, targeted NGS is the optimal tool for assaying edited pools and 
clones, as it provides accurate estimates of indel size, frequency, and sequence identity.
Material and Methods
Cell culture and nucleofection. K562 and N2a cells were obtained from ATCC and cultured in IMDM 
(Gibco) and MEM (Gibco) basal media, respectively, at 37 °C in 5% CO2. Each culture medium was supple-
mented with 10% FBS (Gibco), GlutaMAX (Gibco), and Penicillin/Streptomycin (Gibco). We transfected 
200 ng (0.13 pmol) sgRNA and 500 ng (0.1 pmol) Cas9 pDNA in 2.5 × 105 cells via nucleofection (Lonza 
4D-Nucleofector, X Unit). The Cas9 expression vector (p3a-Cas9HC) was a gift from Jin-Soo Kim (Addgene 
plasmid #43945)24. Single cell sorting was performed on the MoFlo Cell Sorter (Beckman Coulter) at the Siteman 
Flow Cytometry Core at Washington University in St. Louis or at the Flow Cytometry Core at St. Jude Children’s 
Research Hospital.
Plasmid construction. All sgRNA plasmids were assembled by annealing complementary oligonucleo-
tides (IDT) of the 20-nucleotide target sequence flanked by BsmBI sites, cutting with BsmBI (NEB), and ligating 
the product with T7 DNA ligase (Intact Genomics) to the MLM3636 sgRNA expression vector (gift from Keith 
Joung, Addgene plasmid # 43860), as previously described25.
Mismatch detection assay. Genomic DNA was extracted with 500 µL extraction buffer (10 mM Tris, pH 8; 
2 mM EDTA; 0.2% Triton X-100; 200 µg/mL proteinase K) heated at 65 °C for 15 min, followed by 95 °C for 5 min. 
Target regions were PCR-amplified (see Table S2 for primer sequences) with EconoTaq PLUS GREEN 2X Master 
Mix (Lucigen) or AccuPrime Taq DNA Polymerase, High Fidelity (ThermoFisher), according to manufacturer 
protocol. PCR products were denatured at 95 °C for 10 min and re-annealed at −2 °C per second temperature 
ramp to 85 °C, followed by a −1 °C per second ramp to 25 °C. The heterocomplexed PCR product (5 µL) was incu-
bated with 5 U T7E1 enzyme (New England Bio Labs) at 37 °C for 20 min. Products from mismatch assays were 
electrophoresed on a Novex 10% TBE gel (Invitrogen). Densitometry analysis was performed with ImageJ26. The 
estimated percent NHEJ was calculated with the following formula:
= × − −%NHEJ events 100 [1 (1 fraction cleaved) ],(1/2)
where the fraction cleaved is defined as .   
   +   
(density of digested products)
(density of digested products undigested parental band)
Next-generation sequencing. Libraries were made with a two-step PCR protocol, in which the tar-
get genomic site of interest was first amplified (Step1) with primer containing partial Ilumina sequenc-
ing adaptors followed by a second PCR with primers that contained indices and necessary Illumina 
sequencing adapters (Step2). Briefly, target regions were amplified with locus-specific primers (Table S2), con-
taining universal 5′ tails on the forward (5′-CACTCTTTCCCTACACGACGCTCTTCCGATCT-3′) and reverse 
(5′-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-3′) primers. PCR amplifications were performed 
with EconoTaq PLUS GREEN 2X Master Mix or AccuPrime Taq DNA Polymerase, High Fidelity, according to 
the manufacturer protocol. Indexing of the Step1 PCR product was performed by using 0.1X volume from Step1 
with indexing primers and melting at 94 °C for 2 min, followed by five cycles of 94 °C for 30 sec, 54 °C for 30 sec, 
and 72 °C for 40 seconds. We generated 2 × 250 reads with the Illumina MiSeq platform at the Center for Genome 
Sciences and Systems Biology (Washington University) or the Hartwell Center (St. Jude).
TIDE. Sanger traces were generated by GENEWIZ or the Hartwell Center (St. Jude) with target-specific PCR 
products and analyzed with the TIDE webtool (http://tide.nki.nl)18. Default parameters were used for the analysis 
with the exception of the indel size range, which was set from 10–35 bp.
IDAA. The IDAA assay was performed as previously described19. In brief, three primers were used to amplify 
and label each amplicon: a gene specific forward primer with common 5′ tail (5′CACTCTTTCCCTACACGACG 
3′), a gene specific reverse primer, and a Fam-6 common forward primer that anneals to the common tail of the 
gene-specific forward primer (Supplemental Table 2). Primers were used in a 1:10:10 ratio of forward primer: 
FAM-6 labeled primer: reverse primer. Accuprime HiFi polymerase (ABI/Life Technologies) was used for ampli-
fication and touchdown thermocycling conditions were used as previously described19. PCRs were diluted 1:10 
and mixed with LIZ500 or LIZ600 size standards (ABI/Life Technologies) and applied to fragment analysis on 
a ABI 3730xl sequencer (ABI/Life Technologies). Data was analysed using Peak Scanner 2 software (ABI/Life 
Technologies).
Data Availability. All data generated or analyzed during this study are included in this published article (and 
its Supplementary Information files.
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